Anurag Khetan, PhD

Global Upstream and Cell Line Development at Bristol Myers Squibb

Advisor

Anurag Khetan heads the Early Biologics Process Development department of Bristol-Myers Squibb based in NJ. His team interfaces with Discovery and carries out process development of biologics and viral gene therapy programs ranging from molecular biology, cell line development, upstream and downstream development, and associated process analytics.

Anurag has a PhD in Biochemical Engineering from the Hu group at the University of Minnesota. Anurag has had sustained contributions over nearly two decades in the industry ranging from early and late process development, post-approval development, manufacturing support, and GMP manufacturing at Merck, Biogen, Boehringer Ingelheim and BMS.